SHANK1 is abnormally and highly expressed in colon cancer; knockdown of SHANK1 inhibits the survival, proliferation, and migration of colon cancer cells through the AKT/mTOR signaling pathway. Here, AKT1 is linked to malignant colon neoplasm.